Phosphagenics Limited


Phosphagenics is a Melbourne-based, globally driven biotechnology company focused on the discovery of new and cost effective ways to enhance the bioavailability, activity, safety and delivery of proven pharmaceutical and nutraceutical products.

Phosphagenics' core technology is built around the science and application of phosphorylation, a process where the addition of a phosphate group has been found to enhance the bioavailability, activity and safety of existing pharmaceuticals and nutraceuticals, as well as to assist in the production of drug delivery platforms.

Phosphagenics' shares are listed on the Australian Stock Exchange (POH) and the London Stock Exchange's Alternative Investment Market (PSG). An ADR - Level 1 program was established in the U.S. with The Bank of New York Mellon (PPGNY) for U.S. investors to trade in Phosphagenics' stock on the 'over-the-counter' market. In July 2007, this was upgraded to the International OTCQX, a new premium market tier in the U.S. for international exchange-listed companies, operated by Pink Sheets, LLC. 



オーストラリア市場レポート 2011年2月7日: Automotive Technology Group (ASX:ATJ) が世界で最も効率の高いスーパーチャージャーシステムを発表

🕔2/7/2011 1:30:00 PM 11007

オーストラリア市場レポート 2011年2月7日: Automotive Technology Group Limited (ASX:ATJ) が同社のSprintex (R) スーパーチャージャーが世界で最も効率の高い自動車用スーパーチャージャーシステムであると発表。石炭研究によりボツワナにある Aviva Corporation Limited (ASX:AVA) の Mmamantswe プロジェクトにおける輸出グレード熱石炭の将来性を確認。 EnviroGold Limited (ASX:EVG) は南米での同社経営体制を大幅に強化。 Phosphagenics Limited (ASX:POH) (PINK:PPGNY) は米国での乾癬薬品開発に向けた提携を発表。


82,627 会社概要の閲覧回数

  • 日本語ページ閲覧回数: (過去7日間: 10) (過去30日間: 34) (発行以降: 8787) 


  • 03 9605 5999 
  • 主要部門
  • 医学-薬物 
  • 主要業種
  • バイオテクノロジー 
  • ホームページ